Table 2.
Proportion of patients with non-prompt presentation and respective unadjusted and adjusted odds ratios (n = 10,297)
| % Non-prompt (15+ days) presentation1 | Unadjusted odds ratios for non-prompt (15+ days) presentation | Adjusted odds ratios for non-prompt presentation (15+ days) by patient characteristic and cancer diagnosis | |||
|---|---|---|---|---|---|
| Age | |||||
| 15–44 (N = 784) | 44.0 | 0.94 (0.80–1.10) | p < 0.0001 | 0.99 (0.84–1.17) | p = 0.0003 |
| 45–54 (N = 1,220) | 46.8 | 1.05 (0.92–1.20) | 1.12 (0.98–1.30) | ||
| 55–64 (N = 2,170) | 45.3 | 0.99 (0.88–1.11) | 0.98 (0.87–1.10) | ||
| 65–74 (N = 2,807) | 45.6 | Baseline | Baseline | ||
| 75–84 (N = 2,459) | 40.5 | 0.81 (0.73–0.90) | 0.83 (0.74–0.93) | ||
| 85+ (N = 857) | 38.6 | 0.75 (0.64–0.88) | 0.83 (0.70–0.98) | ||
| Gender | |||||
| Male (N = 5,028) | 45.5 | Baseline | p = 0.0008 | Baseline | p = 0.17 |
| Female (N = 5,269) | 42.2 | 0.87 (0.81–0.95) | 0.93 (0.84–1.03) | ||
| Cancer type | |||||
| Bladder (N = 601) | 25.8 | 0.43 (0.35–0.53) | p < 0.0001 | 0.42 (0.34–0.52) | p < 0.0001 |
| Renal (N = 209) | 30.1 | 0.53 (0.39–0.73) | 0.51 (0.37–0.71) | ||
| Brain (N = 125) | 35.2 | 0.67 (0.46–0.99) | 0.66 (0.45–0.98) | ||
| Breast (N = 2,124) | 35.5 | 0.68 (0.58–0.79) | 0.67 (0.57–0.78) | ||
| Unknown primary (N = 110) | 37.3 | 0.73 (0.49–1.10) | 0.75 (0.50–1.12) | ||
| Leukaemia (N = 239) | 39.7 | 0.81 (0.61–1.08) | 0.78 (0.58–1.03) | ||
| Prostate (N = 1,386) | 41.3 | 0.87 (0.74–1.02) | 0.83 (0.70–0.98) | ||
| Pancreatic (N = 272) | 40.4 | 0.84 (0.64–1.10) | 0.85 (0.65–1.11) | ||
| Stomach (N = 187) | 44.4 | 0.98 (0.72–1.34) | 0.99 (0.73–1.35) | ||
| Lung (N = 1,126) | 44.8 | Baseline | Baseline | ||
| Myeloma (N = 127) | 45.7 | 1.04 (0.72–1.50) | 1.01 (0.70–1.47) | ||
| Endometrial (N = 311) | 46.9 | 1.09 (0.85–1.40) | 1.08 (0.84–1.40) | ||
| Ovarian (N = 270) | 46.7 | 1.08 (0.83–1.41) | 1.09 (0.83–1.43) | ||
| Lymphoma (N = 482) | 49.6 | 1.21 (0.98–1.50) | 1.15 (0.93 - 1.43) | ||
| Melanoma (N = 477) | 54.7 | 1.49 (1.20–1.85) | 1.41 (1.13–1.75) | ||
| Colorectal (N = 1,697) | 53.7 | 1.43 (1.23–1.66) | 1.43 (1.23–1.67) | ||
| Oesophageal (N = 407) | 61.2 | 1.94 (1.54–2.45) | 1.94 (1.54–2.45) | ||
| Oropharynheal (N = 147) | 66.0 | 2.39 (1.67–3.43) | 2.26 (1.57–3.25) | ||
| Housebound | |||||
| No (N = 9,707) | 44.4 | Baseline | p < 0.0001 | Baseline | p < 0.0001 |
| Yes (N = 590) | 33.9 | 0.64 (0.54–0.77) | 0.67 (0.56–0.81) | ||
1
This column repeats information presented in Table2, for ease of reference regarding crude proportions.